Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation Approach

We present a complex bifurcation lesion treated with a new two-stent strategy combining a dedicated sirolimus eluting bifurcation stent, BiOSS Lim, with a bioresorbable vascular scaffold (BVS). The advantages of this strategy compared with the conventional two-stent approach are as follows: the dedi...

Full description

Bibliographic Details
Main Authors: Javier Benezet, Antonio Agarrado, Jesús Oneto
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2016/8402942
id doaj-40ce9412fae64f45ba26462e33eca165
record_format Article
spelling doaj-40ce9412fae64f45ba26462e33eca1652020-11-24T23:22:37ZengHindawi LimitedCase Reports in Cardiology2090-64042090-64122016-01-01201610.1155/2016/84029428402942Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation ApproachJavier Benezet0Antonio Agarrado1Jesús Oneto2Department of Cardiology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Ronda de Circunvalación s/n, 11407 Cádiz, SpainDepartment of Cardiology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Ronda de Circunvalación s/n, 11407 Cádiz, SpainDepartment of Cardiology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Ronda de Circunvalación s/n, 11407 Cádiz, SpainWe present a complex bifurcation lesion treated with a new two-stent strategy combining a dedicated sirolimus eluting bifurcation stent, BiOSS Lim, with a bioresorbable vascular scaffold (BVS). The advantages of this strategy compared with the conventional two-stent approach are as follows: the dedicated stent protects the carina from being damaged, the large cell at the middle zone of the BiOSS Lim gives possibility to enter easily into the side branch (SB) with any standard size conventional device, and, finally, the additional use of BVS in the SB could have a long-term benefit in terms of restenosis.http://dx.doi.org/10.1155/2016/8402942
collection DOAJ
language English
format Article
sources DOAJ
author Javier Benezet
Antonio Agarrado
Jesús Oneto
spellingShingle Javier Benezet
Antonio Agarrado
Jesús Oneto
Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation Approach
Case Reports in Cardiology
author_facet Javier Benezet
Antonio Agarrado
Jesús Oneto
author_sort Javier Benezet
title Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation Approach
title_short Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation Approach
title_full Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation Approach
title_fullStr Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation Approach
title_full_unstemmed Treatment of a Coronary Bifurcation Lesion Using One Dedicated Sirolimus Eluting Bifurcation Stent in Combination with a Bioresorbable Vascular Scaffold: A Novel Option for Coronary Bifurcation Approach
title_sort treatment of a coronary bifurcation lesion using one dedicated sirolimus eluting bifurcation stent in combination with a bioresorbable vascular scaffold: a novel option for coronary bifurcation approach
publisher Hindawi Limited
series Case Reports in Cardiology
issn 2090-6404
2090-6412
publishDate 2016-01-01
description We present a complex bifurcation lesion treated with a new two-stent strategy combining a dedicated sirolimus eluting bifurcation stent, BiOSS Lim, with a bioresorbable vascular scaffold (BVS). The advantages of this strategy compared with the conventional two-stent approach are as follows: the dedicated stent protects the carina from being damaged, the large cell at the middle zone of the BiOSS Lim gives possibility to enter easily into the side branch (SB) with any standard size conventional device, and, finally, the additional use of BVS in the SB could have a long-term benefit in terms of restenosis.
url http://dx.doi.org/10.1155/2016/8402942
work_keys_str_mv AT javierbenezet treatmentofacoronarybifurcationlesionusingonededicatedsirolimuselutingbifurcationstentincombinationwithabioresorbablevascularscaffoldanoveloptionforcoronarybifurcationapproach
AT antonioagarrado treatmentofacoronarybifurcationlesionusingonededicatedsirolimuselutingbifurcationstentincombinationwithabioresorbablevascularscaffoldanoveloptionforcoronarybifurcationapproach
AT jesusoneto treatmentofacoronarybifurcationlesionusingonededicatedsirolimuselutingbifurcationstentincombinationwithabioresorbablevascularscaffoldanoveloptionforcoronarybifurcationapproach
_version_ 1725567274336649216